Real-life prospective study on tocilizumab in severe COVID-19 infection

被引：0
|
作者：
Power, L. [1 ]
Morarasu, B. [1 ]
Sarfaraz, A. [1 ]
Basirat, A. [1 ]
Rahman, H. [1 ]
Donnelly, S. [1 ]
Moloney, E. [1 ]
Kooblall, M. [1 ]
Lane, S. [1 ]
机构：
[1] Tallaght Univ Hosp, Dublin, Ireland
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Covid-19; Treatments; Acute respiratory failure;
D O I：
10.1183/13993003.congress-2022.3708
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3708
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
    Erich Pawelka
    Mario Karolyi
    Theresa Mader
    Sara Omid
    Hasan Kelani
    Sebastian Baumgartner
    Sarah Ely
    Wolfgang Hoepler
    Bernd Jilma
    Franz Koenig
    Hermann Laferl
    Marianna Traugott
    Michael Turner
    Tamara Seitz
    Christoph Wenisch
    Alexander Zoufaly
    [J]. Infection, 2021, 49 : 907 - 916
  • [22] Tocilizumab in patients with severe COVID-19: a retrospective cohort study
    Guaraldi, Giovanni
    Meschiari, Marianna
    Cozzi-Lepri, Alessandro
    Milic, Jovana
    Tonelli, Roberto
    Menozzi, Marianna
    Franceschini, Erica
    Cuomo, Gianluca
    Orlando, Gabriella
    Borghi, Vanni
    Santoro, Antonella
    Di Gaetano, Margherita
    Puzzolante, Cinzia
    Carli, Federica
    Bedini, Andrea
    Corradi, Luca
    Fantini, Riccardo
    Castaniere, Ivana
    Tabbi, Luca
    Girardis, Massimo
    Tedeschi, Sara
    Giannella, Maddalena
    Bartoletti, Michele
    Pascale, Renato
    Dolci, Giovanni
    Brugioni, Lucio
    Pietrangelo, Antonello
    Cossarizza, Andrea
    Pea, Federico
    Clini, Enrico
    Salvarani, Carlo
    Massari, Marco
    Viale, Pier Luigi
    Mussini, Cristina
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (08): : E474 - E484
  • [23] COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study
    Olivier, Molinier
    Julian, Pinsolle
    Acya, Bizieux-Thaminy
    Sophie, Schneider
    Benoit, Godbert
    Laurent, Portel
    Hugues, Francois
    Charles, Dayen
    Julie, Obert
    Cecile, Dujon
    Patrick, Dumont
    Sylvie, Julien
    Nicolas, Meyer
    Alexia, Letierce
    Hugues, Morel
    Didier, Debieuvre
    [J]. RESPIRATORY MEDICINE AND RESEARCH, 2024, 86
  • [24] Early tocilizumab treatment was associated with survival benefits in hospitalized kidney transplants with severe COVID-19 infection: A prospective cohort study
    Tang, Yangming
    Yin, Saifu
    Zhang, Haohan
    Wu, Lijuan
    Fan, Yu
    Lin, Tao
    Song, Turun
    [J]. TRANSPLANT IMMUNOLOGY, 2024, 87
  • [25] OLAP over Big COVID-19 Data: A Real-Life Case Study
    Cuzzocrea, Alfredo
    Leung, Carson K.
    Soufargi, Selim
    Gallo, Carmine
    Shang, Siyuan
    Chen, Yubo
    [J]. 2022 IEEE INTL CONF ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING, INTL CONF ON PERVASIVE INTELLIGENCE AND COMPUTING, INTL CONF ON CLOUD AND BIG DATA COMPUTING, INTL CONF ON CYBER SCIENCE AND TECHNOLOGY CONGRESS (DASC/PICOM/CBDCOM/CYBERSCITECH), 2022, : 1110 - 1115
  • [26] Repurposed Tocilizumab in Patients with Severe COVID-19
    Tian, Jianbo
    Zhang, Ming
    Jin, Meng
    Zhang, Fengqin
    Chu, Qian
    Wang, Xiaoyang
    Chen, Can
    Yue, Huihui
    Zhang, Li
    Du, Ronghui
    Zhao, Dong
    Zeng, Zhaofu
    Zhao, Yang
    Liu, Kui
    Wang, Mengmei
    Hu, Ke
    Miao, Xiaoping
    Zhang, Huilan
    [J]. JOURNAL OF IMMUNOLOGY, 2021, 206 (03): : 599 - 606
  • [27] Tocilizumab in severe COVID-19: A promise fulfilled
    Levi, Marcel
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 95 : 38 - 39
  • [28] Tocilizumab is recommended for the treatment of severe COVID-19
    Zhou, Yonggang
    Wei, Haiming
    [J]. EBIOMEDICINE, 2020, 61
  • [29] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Fioravanti, Antonella
    Porcelli, Brunetta
    Terzuoli, Lucia
    Bacarelli, Maria Romana
    Tenti, Sara
    Cheleschi, Sara
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (09) : 891 - 892
  • [30] Tocilizumab, Adipokines and Severe Complications of COVID-19
    Antonella Fioravanti
    Brunetta Porcelli
    Lucia Terzuoli
    Maria Romana Bacarelli
    Sara Tenti
    Sara Cheleschi
    [J]. Clinical Drug Investigation, 2020, 40 : 891 - 892
12345